Client News

Mainz Biomed Initiates Feasibility Study of Biomarker Panel in Pancreatic Cancer Project

DEBRA Research Announces Grant Opportunity for Epidermolysis bullosa Invitation to Submit Proposals

ViGeneron Rebrands as VeonGen Therapeutics and Announces FDA Rare Pediatric Disease Designation and Clinical Progress for Lead Gene Therapy VG801 in Stargardt Disease

Lucentis® biosimilar FYB201/Ranivisio® (ranibizumab) approved in Brazil

leon-nanodrugs appoints Dr. Wolfgang Hofmann as Chief Executive Officer as company’s products approach market

Mallia sets strategic course for future and completes €5.5 million financing

Molecular Health and Axxam enter into a strategic partnership to bolster the discovery of innovative targets in drug development

Abivax Presents First Quarter 2025 Financial Results

DEBRA Research and Dermaliq Enter into a Strategic Collaboration to Advance Cutaneous Drug Delivery for Epidermolysis Bullosa

InflaRx Announces Outcome of Interim Analysis for Vilobelimab Phase 3 Trial in Pyoderma Gangrenosum